ZLN005, also known as 2-(4-tert-Butylphenyl) benzimidazole, is a PGC-1α transcriptional regulator shows antidiabetic efficacy in a mouse model. ZLN005是新型过氧化物增殖激活受体协同激活子(PGC-1α)转录调节剂。